dynorphin B (Human) [3125]



dynorphin B (Human)


SMILES CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(C)C)C(C)C
InChIKey AGTSSZRZBSNTGQ-ITZCFHCWSA-N
Sequence YGGFLRRQFKVVT
HELM PEPTIDE1{Y.G.G.F.L.R.R.Q.F.K.V.V.T}$$$$

Chemical Properties

Hydrogen bond acceptors 20
Hydrogen bond donors 22
Rotatable bonds 51
Log P -4.847
Molecular weight (Da) 1569.9
Stereochemistry info partial

Database connections

Model (AF2) κ δ μ

Bioactivities

Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database
Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database

dynorphin B (Human)


Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections

Model (AF2) κ δ μ

Compound is not listed as a drug.